Patents by Inventor Jeffery Fairman

Jeffery Fairman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PERIODONTITIS VACCINE AND RELATED COMPOSITIONS AND METHODS OF USE
    Publication number: 20240131134
    Abstract: An immunogenic composition, a periodontal vaccine formulation containing the immunogenic composition, and methods for treating or preventing periodontal disease are provided, where the methods involves administering an immunologically effective amount of the composition or vaccine formulation to a subject.
    Type: Application
    Filed: May 29, 2023
    Publication date: April 25, 2024
    Inventor: Jeffery FAIRMAN
  • Periodontitis vaccine and related compositions and methods of use
    Patent number: 11701414
    Abstract: An immunogenic composition, a periodontal vaccine formulation containing the immunogenic composition, and methods for treating or preventing periodontal disease are provided, where the methods involves administering an immunologically effective amount of the composition or vaccine formulation to a subject.
    Type: Grant
    Filed: May 5, 2021
    Date of Patent: July 18, 2023
    Assignee: Vaxcyte, Inc.
    Inventor: Jeffery Fairman
  • PERIODONTITIS VACCINE AND RELATED COMPOSITIONS AND METHODS OF USE
    Publication number: 20210361756
    Abstract: An immunogenic composition, a periodontal vaccine formulation containing the immunogenic composition, and methods for treating or preventing periodontal disease are provided, where the methods involves administering an immunologically effective amount of the composition or vaccine formulation to a subject.
    Type: Application
    Filed: May 5, 2021
    Publication date: November 25, 2021
    Inventor: Jeffery FAIRMAN
  • Periodontitis vaccine and related compositions and methods of use
    Patent number: 10835590
    Abstract: An immunogenic composition, a periodontal vaccine formulation containing the immunogenic composition, and methods for treating or preventing periodontal disease are provided, where the methods involves administering an immunologically effective amount of the composition or vaccine formulation to a subject.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: November 17, 2020
    Assignee: Vaxcyte, Inc.
    Inventor: Jeffery Fairman
  • Subunit vaccines for herpes viruses and methods of use
    Patent number: 9089537
    Abstract: The present disclosure generally relates to vaccine compositions for Herpes Simplex Viruses (HSV) types 1 and/or 2. The vaccines comprise isolated antigens or glycoprotein subunits of the viruses, optionally with an adjuvant, such as a cationic liposome DNA complex (CLDC). Also the present disclosure contains methods of vaccinating a subject utilizing these compositions.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: July 28, 2015
    Assignees: The Trustees of the University of Pennslyvania, Juvaris Biotherapeutics, Inc.
    Inventors: Jeffery Fairman, Gary H. Cohen, Roselyn J. Eisenberg
  • Enhancement of an immune response by administration of a cationic lipid-DNA complex (CLDC)
    Patent number: 8945590
    Abstract: This invention relates to a method for vaccination which is effective for eliciting an enhanced antigen-specific immune response in a mammal, fish or bird. The method is particularly effective for protecting a mammal, fish or bird from a disease including cancer, a disease associated with allergic inflammation, or an infectious disease. Also disclosed are therapeutic compositions useful in such a method.
    Type: Grant
    Filed: March 25, 2009
    Date of Patent: February 3, 2015
    Assignee: Juvaris BioTherapeutics, Inc.
    Inventors: Jeffery Fairman, Marla Lay Vaughn
  • Subunit Vaccines for Herpes Viruses and Methods of Use
    Publication number: 20130171234
    Abstract: The present disclosure generally relates to vaccine compositions for Herpes Simplex Viruses (HSV) types 1 and/or 2. The vaccines comprise isolated antigens or glycoprotein subunits of the viruses, optionally with an adjuvant, such as a cationic liposome DNA complex (CLDC). Also the present disclosure contains methods of vaccinating a subject utilizing these compositions.
    Type: Application
    Filed: February 25, 2011
    Publication date: July 4, 2013
    Inventors: Jeffery Fairman, Gary H. Cohen, Roselyn J. Eisenberg
  • VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES
    Publication number: 20100086584
    Abstract: The present disclosure generally relates to a composition comprising one or more peptides selected from influenza virus antigenic peptides M2e, HA0, BM2 and a M2e-BM2 fusion peptide in a composition with a cationic liposome delivery vehicle, and the use of these compositions as a universal vaccine against influenza A and/or B viral strains.
    Type: Application
    Filed: September 18, 2009
    Publication date: April 8, 2010
    Applicant: Juvaris BioTherapeutics, Inc.
    Inventors: Bernadette Callejo, Tom Monath, Jeffery Fairman
  • Enhancement of an Immune Response by Administration of a Cationic Lipid-DNA Complex (CLDC)
    Publication number: 20090263423
    Abstract: This invention relates to a method for vaccination which is effective for eliciting an enhanced antigen-specific immune response in a mammal, fish or bird. The method is particularly effective for protecting a mammal, fish or bird from a disease including cancer, a disease associated with allergic inflammation, or an infectious disease. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: March 25, 2009
    Publication date: October 22, 2009
    Applicant: Juvaris BioTherapeutics, Inc.
    Inventors: Jeffery Fairman, Marla Lay Vaughn
  • Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes
    Publication number: 20090169612
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, or an infectious disease. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: September 30, 2008
    Publication date: July 2, 2009
    Applicants: Juvaris Bio Therapeutics, Inc., Colorado State University Research Foundation
    Inventors: Steven W. Dow, Jeffery Fairman
  • Systemic immune activation method using non CpG nucleic acids
    Publication number: 20050181035
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, or an infectious disease. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: February 17, 2004
    Publication date: August 18, 2005
    Inventors: Steven Dow, Jeffery Fairman
  • Vaccines using pattern recognition receptor-ligand:lipid complexes
    Publication number: 20050013812
    Abstract: This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, an infectious disease, or a condition associated with a deleterious activity of a self-antigen. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: July 14, 2003
    Publication date: January 20, 2005
    Inventors: Steven Dow, Jeffery Fairman
  • Systemic immune activation method using nucleic acid-lipid complexes
    Publication number: 20040247662
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, or an infectious disease. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: February 17, 2004
    Publication date: December 9, 2004
    Inventors: Steven W. Dow, Jeffery Fairman
  • Type-C lectins and methods of use
    Publication number: 20030162255
    Abstract: The nucleotide and corresponding protein sequence of a gene belonging to the family of type-C lectins are disclosed.
    Type: Application
    Filed: January 21, 2003
    Publication date: August 28, 2003
    Inventors: Jeffery Fairman, Choong-Chin Liew
  • Methods and Reagents For Diagnosis and Treatment of Insulin Resistance and Related Condition
    Publication number: 20030092028
    Abstract: METHODS AND REAGENTS FOR DIAGNOSIS AND TREATMENT OF INSULIN RESISTANCE AND RELATED CONDITIONSMethods, reagents and devices for diagnosis, prognosis and treatment of insulin resistance and insulin resistance related conditions are provided.
    Type: Application
    Filed: June 3, 2002
    Publication date: May 15, 2003
    Inventors: Yuanhong MA , Chih-Jian LIH , Fan CHEN , Jeffery FAIRMAN , Yii-Der CHEN